Advent International has acquired a majority stake in Encora, a digital engineering services company. No financial terms were disclosed. As part of the deal, Encora’s current majority shareholder, ...

BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...

The acquisition strengthens Encora's digital engineering capabilities and expands its global footprint with new centers across India, Europe, and the Americas. SANTA CLARA, Calif., Feb. 6, 2025 ...

Encora Therapeutics, a clinical-stage medtech company developing a neuromodulation therapy for movement disorders, today announced the appointment of Nadim Yared as Chairman and Chief Executive ...

Softelligence will rebrand to operate under the Encora brand Warburg Pincus invested in Encora in 2019 and Advent acquired a majority stake in 2021 Encora is a global digital engineering services ...

"It is my great honor to welcome Anand to Encora as our next CEO. His deep experience in fast-growing tech and in scaling global businesses through exponential growth, makes him the ideal leader for ...

For millions of Americans with essential tremor, simple tasks like writing a note, putting on makeup or plugging in an appliance can be difficult. In recent years, companies like Cala Health and ...

Outsourced software product development services provider Encora has now gone into the fold of Advent International after the PE firm acquired a majority stake from its US peer Warburg Pincus.

SAN DIEGO, April 14, 2025--(BUSINESS WIRE)--Encora Therapeutics today announced that its abstract, Safety and Efficacy of a Wrist-worn Vibratory Stimulation Wearable for Upper Limb Tremor Reduction in ...

Outsourced product development services provider Encora has acquired Daitan, an American software engineering firm, saying the acquisition will position it to “tap into the tech talent pool” across ...